Efthymiou Stephanie, Han Wenyan, Ilyas Muhammad, Li Jun, Yu Yichao, Scala Marcello, Malintan Nancy T, Ilyas Muhammad, Vavouraki Nikoleta, Mankad Kshitij, Maroofian Reza, Rocca Clarissa, Salpietro Vincenzo, Lakhani Shenela, Mallack Eric J, Palculict Timothy Blake, Li Hong, Zhang Guojun, Zafar Faisal, Rana Nuzhat, Takashima Noriko, Matsunaga Hayato, Manzoni Claudia, Striano Pasquale, Lythgoe Mark F, Aruga Jun, Lu Wei, Houlden Henry
Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
U.O.C. Genetica Medica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genoa, Italy.
Front Mol Neurosci. 2024 Mar 1;17:1222935. doi: 10.3389/fnmol.2024.1222935. eCollection 2024.
This study reports on biallelic homozygous and monoallelic variants in in three unrelated families presenting with epileptic encephalopathy associated with a broad neurological involvement characterized by microcephaly, intellectual disability, seizures, and global developmental delay. encodes for a transmembrane protein that is involved in controlling neurite outgrowth and inhibitory synapse development and that has an important role in brain function and neurological diseases. Using primary cultures of hippocampal neurons carrying patients' SLITRK3 variants and in combination with electrophysiology, we demonstrate that recessive variants are loss-of-function alleles. Immunostaining experiments in HEK-293 cells showed that human variants C566R and E606X change SLITRK3 protein expression patterns on the cell surface, resulting in highly accumulating defective proteins in the Golgi apparatus. By analyzing the development and phenotype of SLITRK3 KO () mice, the study shows evidence of enhanced susceptibility to pentylenetetrazole-induced seizure with the appearance of spontaneous epileptiform EEG as well as developmental deficits such as higher motor activities and reduced parvalbumin interneurons. Taken together, the results exhibit impaired development of the peripheral and central nervous system and support a conserved role of this transmembrane protein in neurological function. The study delineates an emerging spectrum of human core synaptopathies caused by variants in genes that encode SLITRK proteins and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired postsynaptic neurotransmission at nerve terminals; an impaired neurotransmission resulting in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by SLITRK3 mutations highlights the key roles of this gene in human brain development and function.
本研究报告了三个无血缘关系的家族中双等位基因纯合和单等位基因变异情况,这些家族患有癫痫性脑病,并伴有广泛的神经受累,其特征为小头畸形、智力残疾、癫痫发作和全面发育迟缓。[该基因]编码一种跨膜蛋白,该蛋白参与控制神经突生长和抑制性突触发育,在脑功能和神经疾病中起重要作用。利用携带患者SLITRK3变异的海马神经元原代培养物,并结合电生理学方法,我们证明隐性变异是功能丧失等位基因。在HEK - 293细胞中的免疫染色实验表明,人类变异C566R和E606X改变了细胞表面的SLITRK3蛋白表达模式,导致高尔基体中缺陷蛋白高度积累。通过分析SLITRK3基因敲除()小鼠的发育和表型,该研究显示出对戊四氮诱导的癫痫发作易感性增强的证据,伴有自发性癫痫样脑电图的出现以及发育缺陷,如更高的运动活性和减少的小白蛋白中间神经元。综上所述,这些结果表明外周和中枢神经系统发育受损,并支持这种跨膜蛋白在神经功能中的保守作用。该研究描绘了由编码SLITRK蛋白和突触机制重要调节成分的基因变异引起的人类核心突触病的新谱系。这些疾病的标志是神经末梢突触后神经传递受损;神经传递受损导致一系列(通常重叠)临床特征,包括神经发育障碍、虚弱、癫痫发作和异常运动。由SLITRK3突变引起的遗传性突触病突出了该基因在人类大脑发育和功能中的关键作用。